SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
XOMA. Bull or Bear?
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
17367 72 0 XOMA
Emcee:  Olu Emuleomo Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
16392This is a good start for those that don't understand the Psoriasis market. &Bluegreen-11/2/2003
16391Come on Cacaito you know what I meant. There were around 3 thousand people thatBluegreen-11/2/2003
16390..."there were around 3 THOUSAND people in Rapiva trials........just those Cacaito-11/2/2003
16389Bob, most don't understand Psoriasis patient population. THere are probablyBluegreen-11/1/2003
16388Cacaito, I see you spewing garbage again. Man are you foaming at the mouth or wBluegreen-11/1/2003
16387Gw, you were right, Amevive price will drop soon... RELATIVE to Enbrel effectivCacaito-11/1/2003
16386Is it reasonable to expect $100 millions in sales in 2004! THAT is a LOT of monCacaito-11/1/2003
16385That prohost sounds like a 'ahoo poster, what a lack of candor, Raptiva is nCacaito-11/1/2003
16384The cd-20 patent rights were considered at the time to be a "blocking"Robert K.-10/31/2003
16383As a matter of fact I am doing a little research into xoma and cd-20 as we speakRobert K.-10/30/2003
16382I said I "thought " you were a biogen fan and I was attempting to do yRobert K.-10/30/2003
16381Blue, Gw finally admit that as Rkk said he is a Mullen fan, at least a counterCacaito-10/30/2003
16380Tifacogin, the data is out now, follow the main article and the editorial to appCacaito-10/30/2003
16379Robert, Castello seems to plan to sell all the manufacturing capacity to the samCacaito-10/30/2003
16378WOW !!!! READ ALL ABOUT IT!!! Raptiva approved... ...Biogen add$ 500 million$ iCacaito-10/30/2003
16377Did Prohost start coverage in 1992 when xoma was $20 to $30 ???Cacaito-10/30/2003
16376Robert we agree 100%. When you say, " George, i think you like biogen but aknahow-10/30/2003
16375Enbrel is a great drug destined to get greater. However in the first battle betwRobert K.-10/29/2003
16374Congrats on your trade Ed!! Glad to see you making money in the market short orBluegreen-10/29/2003
16373Congats Ed. While I was out of Xoma I did not think shorting it was a good ideaaknahow-10/29/2003
16372Bluegreen, Who is Prohost anyway? The reason Xoma lost value was because the sEdscharp-10/29/2003
16371WOW!!!! READ ALL ABOUT IT!!!!!! PROHOST>>>>>>>>>>Bluegreen-10/29/2003
16370XOMA gets final approval....long hard slog, but can they sell the drug????? biz.Arthur Radley-10/27/2003
16369Blue> a non-xoma patent for you> SUMMARY Epithelial cells which line mucosRobert K.-10/21/2003
16368I saw that link. Have no idea what it means or what they are trying to say. AlsoRobert K.-10/21/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News